Clinical Trials
3 trialsNCT03653546 2025-09-10
BM
Alpha Biopharma (Jiangsu) Co., Ltd.
Phase 2/3 Completed
NCT01363557 2014-05-13
ARPEGE
Assistance Publique - Hôpitaux de Paris
Phase NA Terminated
NCT00238251 2012-06-05
Radiation Therapy Combined With Either Gefitinib or Temozolomide in Pats With NSCLC and Brain Metastases
Swiss Cancer Institute
Phase 2 Completed